Closing Bell: Banking powers to benchmark's 0.33 percent zoom

Friday, November 3 2017

Closing Bell: Banking powers to benchmark's 0.33 percent zoom

Closing Bell: Banking powers to benchmark's 0.33 percent zoom Closing Bell: Banking powers to benchmark's 0.33 percent zoom Source : SIFY 15:58 hrs
Stocks of SBI (up by 3.52%), and LT (2.89%) contributed the most to the Sensex's 0.33% or 112.34 point intra-day gain. The Sensex ended Friday's session on 33685.56, after some buying momentum in auto and banking scrips.Scrips of SBI were up by 10 points. There remained selling pressure on scrips such as Bharti Airtel and pharma stocks, but Banking scrips helped manage momentum,Pharma stocks such as Lupin (down by 1.40%), Sun Pharma (1.99%), were relegated to the bottom, which also read names such as Powergrid (1.95%). Among auto scrips, there was mixed response with Tata Motors (up by 2.81%) contributing the third-best to the Sensex, while others such as Hero Motoco (down by 1.23%), and Bajaj Auto (down by 0.05%), bleeding in the red. On the broader side, the gain small cap stocks fared well, with the BSE SmallCap index chipping in with a robust 0.49% gain. Next50 was trading in the negative with a 0.04% loss, and BSE midcap was down by 12.24 points by the end of trading hours. The top turnovers in the session included the likes of Hathway (up by nearly 20%), Den Networks (10.27%), and Steel Authority of India Limited (8.64%). On the NSE, there was a marginal gain on the benchmark, Nifty50. It ended with a 28.70 point or 0.28% gain to close at 10452.50. The Nifty SML100 free broad market index was up by 0.36%, while among sectoral gainers, PSU bank was up by 3.20% in intra-day trading. On the banking front, both Bank of India and Indian Bank recorded a 52 week high, with an over 4% intra-day trading gain. Pharma stocks had a disappointing outing on the NSE with the sectoral index bleeding a loss of 1.06%. Only Glaxo (1.71%), Dr. Reddy (0.65%), and Cipla (0.63%) could post any worthy intra-day gains. Glenmark bled the most, while Aurobindo Pharma (down by 0.15%) rallied closer to its 52 week high of 804.40 set on 10 November 2016. SEARCH